Tahir Misbah

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$306,202.62

Insider Activity of Tahir Misbah

According to the SEC Form 4 filings, Tahir Misbah, being in a position of

  1. CHIEF FINANCIAL OFFICER at IGM Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10205 shares for $96,299,
    over all time since 2022-05-26, has bought 0 shares, and sold 22480 shares for $306,203.

The largest sale of all time was on 2022-12-19 and amounted to 3801 share of IGM Biosciences, Inc. for $76,020.

Biography of Tahir Misbah

No biography is available at this moment.

2024-12-16SaleIGM Biosciences, Inc.
IGMS
CHIEF FINANCIAL OFFICER
1,708
0.003%
$7.48$12,776-12.03%
2024-09-13SaleIGM Biosciences, Inc.
IGMS
CHIEF FINANCIAL OFFICER
1,487
0.0023%
$11.54$17,158-1.5%
2024-06-14SaleIGM Biosciences, Inc.
IGMS
CHIEF FINANCIAL OFFICER
1,570
0.0025%
$7.58$11,893+41.62%
2024-03-14SaleIGM Biosciences, Inc.
IGMS
CHIEF FINANCIAL OFFICER
2,543
0.0044%
$10.17$25,864-6.76%
2024-03-13SaleIGM Biosciences, Inc.
IGMS
CHIEF FINANCIAL OFFICER
2,897
0.0049%
$9.88$28,608-4.12%
2023-11-27SaleIGM Biosciences, Inc.
IGMS
Chief Financial Officer
1,337
0.0023%
$5.06$6,764+95.67%
2023-05-23SaleIGM Biosciences, Inc.
IGMS
Chief Financial Officer
1,259
0.0029%
$12.31$15,497-24.81%
2023-03-14SaleIGM Biosciences, Inc.
IGMS
Chief Financial Officer
1,768
0.0039%
$18.73$33,118-47.64%
2022-12-19SaleIGM Biosciences, Inc.
IGMS
Chief Financial Officer
3,801
0.0091%
$20.00$76,020-45.78%
2022-12-16SaleIGM Biosciences, Inc.
IGMS
Chief Financial Officer
2,283
0.005%
$18.98$43,339-47.54%
2022-11-23SaleIGM Biosciences, Inc.
IGMS
Chief Financial Officer
877
0.0019%
$21.57$18,918-51%
2022-05-26SaleIGM Biosciences, Inc.
IGMS
Chief Financial Officer
950
0.0023%
$17.10$16,247+17.65%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.